Thermo Fisher Scientific has completed the acquisition of Henogen S.A., Novasep’s viral vector manufacturing business in Belgium for approximately $879 million.   Novasep’s viral vector manufacturing business provides contract manufacturing services for vaccines and therapies to biotechnology companies and large biopharma customers. With two locations in Seneffe and Gosselies, Belgium, Novasep’s viral vector business offers more than 7,000 square meters of clinical and commercial manufactu...